Advertise Your Pathologist, Ph.D. or Related Positions with us!
To post a basic Pathologist / Physician / Ph.D. / Residency job ad, please email the text (Word format, up to 300 words), your logo (optional) and your contact information to Ads@PathologyOutlines.com (please use this email because it is monitored continuously). The cost is $975. Please include a contact email or fax in your ad for a better response. We post or respond within one business day of receipt - if no response, please resend and CC Rosie@PathologyOutlines.com. After posting, we will send you a confirmation email and invoice; please use the link at the bottom of the invoice to pay. Ads are posted until filled, up to 6 months. Prepayment may be required.
We also have these options to further highlight your Jobs post:
(a) $750 to add a banner for one month on the Jobs page (top: 728x90, side: 300x250)
(b) $1,000 to add a standard E-blast or social media post
(c) $500 for a Pathology related (not a doctor) / Available candidate / Seeking a residency ad
(d) For packages of 6 or more ads, contact us at Ads@PathologyOutlines.com
All recent job ads are posted in our biweekly Job email sent to 6,412 subscribers, for no additional charge.
Frequently Asked Questions, Testimonials, US map
List of Residency Directors, List of Pathology Chairs
CALIFORNIA
Director, Division of Molecular Pathology & Cytogenetics
Department of Pathology & Laboratory Medicine
University of California Irvine
IRVINE, CALIFORNIA (USA).
The University of California Irvine (UCI) School of Medicine, Department of Pathology & Laboratory Medicine, invites applications from MD or MD-PhD board-certified molecular pathologists to direct the Division of Molecular Pathology & Cytogenetics. The full-time academic appointment may be at the Assistant or Associate level in the Health Sciences Clinical or Clinical X series, depending on experience and extent of research effort. Clinical X appointments confer membership in the UCI Academic Senate.
As Director of Molecular Pathology & Cytogenetics, the successful recruit will have the administrative and interpersonal skills to effectively lead and coordinate clinical, teaching, and research activities within and beyond the division. Candidates should have extensive and current clinical expertise in Molecular Pathology. Directorship responsibilities will also include a newly-approved Cytogenetics/FISH Laboratory with separate faculty cytogeneticist; accordingly, experience and/or knowledge of cytogenetics lab operations is preferred. Clinical licensure and board certification in Molecular Pathology are required, as is dedication to teaching and mentoring, which will involve medical students, graduate students, residents, fellows, and junior faculty.
Salary and rank will be commensurate with experience. To apply for this position, candidates should upload their curriculum vitae, statements (research, teaching, and diversity), reference information, and additional items to UCI Recruit: https://recruit.ap.uci.edu/apply/JPF05872.
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy. A recipient of an NSF ADVANCE award for gender equity, UCI is responsive to the needs of dual career couples, supports work-life balance through an array of family-friendly policies, and is dedicated to broadening participation in higher education.
[5 December 2019, #9085]
Director, Cytogenetics/FISH Laboratory
Division of Molecular Pathology & Cytogenetics
Department of Pathology & Laboratory Medicine
University of California Irvine
IRVINE, CALIFORNIA (USA).
The University of California Irvine (UCI) School of Medicine, Department of Pathology & Laboratory Medicine, invites applications from PhD, MD, or MD-PhD board-certified/eligible cytogeneticists to direct the Cytogenetics/FISH Laboratory within the Division of Molecular Pathology & Cytogenetics. The full-time academic appointment may be at the Assistant or Associate level in the Health Sciences Clinical or Clinical X series, depending on experience and extent of research effort. Clinical X appointments confer membership in the UCI Academic Senate.
As Director of the Cytogenetics/FISH Laboratory, the successful recruit will have the administrative and interpersonal skills to effectively lead and coordinate clinical, teaching, and research activities within and beyond the division. Candidates should have extensive and current clinical expertise in Cytogenetics. The newly-approved Cytogenetics/FISH Laboratory, with a planned go-live date of July 2020, will be under the Division of Molecular Pathology & Cytogenetics; experience and/or knowledge of molecular pathology operations is preferred, but not required. Clinical licensure and board certification in Cytogenetics are required, as is dedication to teaching and mentoring, which will involve medical students, graduate students, residents, fellows, and junior faculty.
Salary and rank will be commensurate with experience. To apply, candidates should upload their curriculum vitae, statements (research, teaching, and diversity), reference information, and additional items to UCI Recruit: https://recruit.ap.uci.edu/apply/JPF05873.
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy. A recipient of an NSF ADVANCE award for gender equity, UCI is responsive to the needs of dual career couples, supports work-life balance through an array of family-friendly policies, and is dedicated to broadening participation in higher education.
[3 December 2019, #9065]
